Weigao Eyes Automation To Ease Acute Labor Shortage: China Earnings Roundup (Part 4)
This article was originally published in PharmAsia News
Labor shortages and higher salaries have led Shandong Weigao Group Medical Polymer Co. Ltd. to invest in automation as the firm plans to open three more dialysis centers.
You may also be interested in...
HONG KONG - Rising labor costs are putting stress on manufacturing operations in China, but may prove to be a boon in the long term for companies focused on the world's fastest-growing domestic market
China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape
SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions
After securing the first approval globally for an inhaled COVID-19 vaccine, Chinese biotech CanSino CEO Xuefeng Yu sat down with Scrip in this Chinese-language interview to share his views on vaccine development and market opportunities in China and elsewhere.